Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-180-5 | CAS number: 79-14-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- ; 3 minor deviations, insignificant. 4 of the rats, 3.8 mg/L, without gross evaluation at necropsy. No tissues from 2 male rats in the 5.2 mg/L available for microscopy. 0.60 mg/L animals in recovery for 15 days rather 14 days
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- Deviations:
- yes
- Remarks:
- ; 3 minor deviations, insignificant. 4 of the rats, 3.8 mg/L, without gross evaluation at necropsy. No tissues from 2 male rats in the 5.2 mg/L available for microscopy. 0.60 mg/L animals in recovery for 15 days rather 14 days
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-3 (Acute inhalation toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Glycollic acid
- EC Number:
- 201-180-5
- EC Name:
- Glycollic acid
- Cas Number:
- 79-14-1
- Molecular formula:
- C2H4O3
- IUPAC Name:
- 2-hydroxyacetic acid
- Details on test material:
- Glycolic acid 70% solution
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD®(SD)IGS BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Charles River Breeding Laboratories, Raleigh, North Carolina, USA
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- Rats were individually restrained in perforated stainless steel cylinders with conical nose pieces. The restrainers were inserted into the faceplate of the exposure chamber so that only the nose of each rat extended into the chamber. The chamber was a glass cylinder with a nominal internal volume of 34 L. The chamber airflow was set at approximately 12 air changes per hour. Airflow was monitored continually and recorded at 30 minute intervals. Chamber environmental conditions were monitored regularly through exposure.
- Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- gravimetric analysis at 30-45 min intervals during exposure
- Duration of exposure:
- 4 h
- Remarks on duration:
- single exposure period
- Concentrations:
- 0, 0.6, 2.1, 3.8 and 5.2 mg glycolic acid/L air.
Characterization of the chamber atmosphere during each exposure showed the mean total aerosol concentration to be 5.2, 3.8, 2.1 and 0.60 mg/L Glycolic Acid. - No. of animals per sex per dose:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Raleigh, North Carolina.
- Age at study initiation: Approximately 8 weeks old.
- Weight at study initiation: Males ranged from 237 g to 295 g, females ranged from 198 g to 202 g.
- Housing:Singly or in pairs (sexes separate) in suspended, stainless steel, wire mesh cages.
- Diet (e.g. ad libitum): PMI Nutrition International, Inc. Certified Rodent LabDiet 5002 ad libitum.
- Water (e.g. ad libitum): Tap water ad libitum.
- Acclimation period: Quarantined for 6 days prior to testing.
- Dosing: One group of 5 male and 5 female rats and three groups of 10 male rats. Additional satellite groups of 5 rats were tested for the four test concentrations. A control group of 10 rats was used. Additionally, four groups of 5 male rats per dose were used for a satellite experiment.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23+/-1°C.
- Humidity (%): 50 +/- 10%.
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours dark on a timer-controlled cycle - Control animals:
- yes
- Details on study design:
- One group of 5 male and 5 female rats and 3 groups of 10 male rats each were exposed to an atmosphere of Glycolic Acid in air and allowed to recover for 14 or 15 days. These rats were designated for LC50 determination. The 0.60 mg/L group of rats was inadvertently kept for a 15-day recovery period. This deviation did not affect the results of the study. After the recovery period, all surviving rats were sacrificed for gross pathology evaluations. Male and female rats also underwent microscopic examination of the nose, larynx, pharynx, and lungs. Four groups of 5 male rats each were exposed along with the groups designated for LC50 determination. These rats were designated as satellite animals. All surviving satellite animals were sacrificed approximately 24 hours after exposure for microscopic examination of the nose, larynx, pharynx, and lungs. One group of 10 male rats was exposed to air only. These rats were designated as controls. Five control rats were sacrificed approximately 24 hours after exposure for microscopic examination of the nose, larynx, pharynx, and lungs. The remaining 5 rats were allowed to recover for 14 days, then received the same treatment as the control rats from the initial sacrifice. All rats were exposed nose-only for a single 4-hour period.
- Statistics:
- Finney, D.S. (1971). Probit analysis, Third Edition, Cambridge University Press, Cambridge.
Results and discussion
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- > 5.2 mg/L air
- Exp. duration:
- 4 h
- Remarks on result:
- other: nose-only
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 3.6 mg/L air
- 95% CL:
- 2.4 - 8.9
- Exp. duration:
- 4 h
- Remarks on result:
- other: nose-only
- Mortality:
- Exposure to 5.2 mg/L glycolic acid produced 60% mortality in male rats and no mortality in female rats. Subsequent exposures were made on male rats only. Mortality in male rats exposed to 0.6, 2.1 and 3.8 mg/L glycolic acid was 0, 20 and 60% respectively. Rats died either during exposure, or within 1 to 10 days following exposure to the test substance. Mortality was associated with ulcerative lesions founds in the larynges.
- Clinical signs:
- other: Observations for clinical signs commenced after removal of the rats from the restrainers. Signs of toxicity included gasping, lung noise, hunched posture, nasal and ocular discharge. Additional clinical signs noted later during the recovery period includ
- Body weight:
- All exposed rats showed body weight losses the day after exposure. One rat in the 5.2 mg/L treatment and all rats in the 3.8, 2.1 and 0.6 mg/L treatments experienced an overall weight gain during the recovery period, although some transient weight losses did occur.
- Gross pathology:
- No test substance associated target organ gross changes were observed in exposed male or female rats.
Microscopic changes, attributed to treatment induced tissue irritation, were observed in the noses, larynges and lungs of male rats and nose and larynges of female rats. Mild to severe laryngeal ulceration was present in all treated male groups and mild effects were present in the female group. There was not a clear dose response in regard to lesion severity at lower exposure levels, but exposure to 3.8 mg/L and above was associated with severe ulceration. Minimal to mild subacute/chronic inflammation was present in lungs of rats exposed to 2.1, 3.8 and 5.2 mg/L glycolic acid. - Other findings:
- No further information.
Any other information on results incl. tables
Mortality
-No mortality was observed in male rats designated as satellite animals or in control rats.
-5.2 mg/L produced 60% mortality in male rats (3/5) and no mortality in females (0/5).
-Only male rats were used for subsequent exposures at concentrations less than 5.2 mg/L.
-Male rat mortality at the other exposure concentrations were 60% for 3.8 mg/L (6/10), 20% for 2.1 mg/L (2/10), and 0% for 0.60 mg/L (0/10).
Clinical signs
-Clinical signs were collected for LC50 rats, but not for satellite or control rats.
-Immediately following exposure, gasping, lung noise, hunched posture, nasal and ocular discharge were observed. Stained fur, wet fur and perinea were also observed, but attributed to the method of restraint.
-During recovery, gasping, lung noise, hunched posture, lethargy, ocular and nasal discharge, sore eyes, sore nose, sore chin, vocalization, alopecia and stained and/or wet fur and/or perinea were observed
Bodyweight
-Body weights were collected for LC50 rats, but not for satellite or control rats.
-All male rats and 4 of 5 female rats which survived the exposure to 5.2 mg L Glycolic Acid experienced slight to severe body-weight losses the day after exposure. Males lost 12-15% of pre-exposure body weight and females lost 0.1 to 5.1%. All male rats that survived the 3.8 mg/L exposure had losses that ranged from 6.5 to 16% of pre-exposure body weight. Rats from the 2.1 mg/L group showed losses that ranged from 2.4 to 14 % of pre-exposure body weight and rats from the 0.60 mg/L group exhibited losses that ranged from 0.3 to 14% of pre-exposure body weight. One rat in the 5.2 mg/L group and all rats in the 3.8, 2.1 or 0.60 mg/L groups experienced overall weight gain during the recovery period, though some transient weight losses did occur.
Pathology
No test substance-associated target organ gross changes were observed in exposed male or female rats designated for LC50 determination. Four male rats exposed to 3.8 mg/L did not receive gross evaluations due to inadvertent errors at necropsy.
Other findings
Microscopic Observations
- Test substance-associated microscopic changes, attributable to tissue irritation, were observed in noses, larynges and lungs of male rats and nose and larynges of female rats. Minimal to mild nasal lesions, seen in all treated groups, consisted of degeneration of respiratory and/or olfactory epithelium. In the respiratory region, changes were in the mucosa lining the dorsal, middle and ventral meatuses, and on the septum and turbinates of the anterior nose. The changes consisted of loss of columnar and/or transitional cells and denudation of mucosal epithelium or presence of degenerate acidophilic cells or basophilic regenerative cells, occasionally flattened to cover maximal surface area. In the olfactory region, changes were on the septum and ethmoid turbinates and ranged from segmental loss of neuroepithelial cells, the usual, to occasional loss of neuroepithelial and sustentacular cells, resulting in mucosal denudation. Regeneration was noted as basophilic, slightly disorganized hypercellular segments of olfactory mucosa.
-Mild to severe laryngeal ulceration was present in all treated male groups and mild effects were present in the female group. In most instances, sections of larynges were examined microscopically at the base of the epiglottis and ventral pouch region. There was not a clear dose response in regard to lesion severity at lower exposure levels, but exposure to 3.8 mg/L and above was associated with severe ulceration.
- Minimal to mild subacute/chronic inflammation was present in lungs of rats exposed to 2.1, 3.8, and 5.2 mg/L Glycolic Ac
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- For nose only exposure:
female 4 hour LC50 = >5.2 mg/L
male 4 hour LC50 = 3.6 mg/L (95% confidence limits of 2.4 – 8.9 mg/L).
Based on the microscopic pathology observations, the no-observed-effect level (NOEL) for a single 4-hour exposure to aerosols of glycolic acid in male and female rats was not established.
The purpose of this study was two-fold. The primary purpose was to determine a 4-hour inhalation LC50 for Glycolic Acid in male and female rats. The secondary purpose was to evaluate the potential of the test substance to induce lesions in the nose, pharynx, larynx and lungs following a single 4-hour inhalation exposure.
Under the conditions of this study, the 4-hour inhalation median lethal concentration (LC50) for Glycolic Acid in female rats was greater than 5.2 mg/L. The 4-hour LC50 for Glycolic Acid in male rats was 3.6 mg/L (95% confidence limits 2.4-8.9 mg/L). Based upon the microscopic pathology observations, the no-observed-effect level for a single 4-hour exposure to aerosols of Glycolic Acid in male and female rats was not established. - Executive summary:
For nose only exposure: female 4 hour LC50= >5.2 mg/L, male 4 hour LC50= 3.6 mg/L (95% confidence limits of 2.4 – 8.9 mg/L). Based on the microscopic pathology observations, the no-observed level (NOEL) for a single 4 -hour exposure to aerosols of glycolic acid in male and female rats was not established. Under the conditions of this study, Glycolic acid is considered harmful by inhalation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.